Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pronucleotein Biotechnologies

Pronucleotein Biotechnologies
2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of deoxyribonucleic acid aptamer sequences and conjugates. The company's diagnostic platform for development and commercialization of a new food safety testing system can be used at any point in the global food supply chain, and provide results onsite within 30 minutes.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
CibusDx
Primary Office
  • 4100 North West Loop 410
  • Suite 230
  • San Antonio, TX 78229
  • United States

Pronucleotein Biotechnologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request full access to PitchBook

Pronucleotein Biotechnologies Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request full access to PitchBook

Pronucleotein Biotechnologies Executive Team (4)

Name Title Board
Seat
Contact
Info
John Millice President
John Bruno Ph.D Vice President & Chief Technology Officer
Lynda de la Vina Co-Founder & Director

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »